<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="216912">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00261144</url>
  </required_header>
  <id_info>
    <org_study_id>Cell 101</org_study_id>
    <nct_id>NCT00261144</nct_id>
  </id_info>
  <brief_title>Collagenase in the Treatment of Cellulite</brief_title>
  <official_title>Collagenase in the Treatment of Cellulite</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stony Brook University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stony Brook University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if collagenase injection will reduce or eliminate
      the appearance of cellulite of the thigh.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is an open label study of collagenase injection therapy for reduction and/or
      elimination of cellulite of the posterolateral thighs.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">March 2014</completion_date>
  <primary_completion_date type="Anticipated">February 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Reduction and/or elimination of cellulite in the posterolateral thigh</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Cellulite</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Collagenase</intervention_name>
    <description>One 0.58mg injection every two weeks for six weeks (total three 0.58mg injections)</description>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Biological</intervention_name>
    <description>Collagenase injection</description>
    <other_name>Collagenase</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  10 x 10 cm area of cellulite of the posterolateral thigh(s)

        Exclusion Criteria:

          -  any chronic, serious or uncontrolled medical condition

          -  inability to conform to study visits (12-15 per year)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marie A Badalamente, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. Orthopaedics, SUNY@Stony Brook, NY 11794</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Alexander B Dagum, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dept. Surgery, SUNY@Stony Brook, NY 11794</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marie A Badalamente, PhD</last_name>
    <phone>631 444 2215</phone>
    <email>Marie.Badalamente@stonybrookmedicine.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gail Trocchio</last_name>
    <phone>631 444 2215</phone>
    <email>Gail.Trocchio@stonybrookmedicine.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Dept. Orthopaedics, SUNY Stony Brook</name>
      <address>
        <city>Stony Brook</city>
        <state>New York</state>
        <zip>11794</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marie A Badalamente, PhD</last_name>
      <phone>631-444-2215</phone>
      <email>Marie.Badalamente@stonybrookmedicine.edu</email>
    </contact>
    <contact_backup>
      <last_name>Gail Trocchio</last_name>
      <phone>631 444 2215</phone>
      <email>Gail.Trocchio@stonybrookmedicine.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Marie A Badalamente, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alexander B Dagum, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2012</verification_date>
  <lastchanged_date>December 11, 2012</lastchanged_date>
  <firstreceived_date>November 30, 2005</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Stony Brook University</investigator_affiliation>
    <investigator_full_name>Marie A. Badalamente</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
